An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 207103
Company: PFIZER

Summary Review

Products on NDA 207103

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
IBRANCE	PALBOCICLIB	75MG	CAPSULE;ORAL	Prescription	None	Yes	No
IBRANCE	PALBOCICLIB	100MG	CAPSULE;ORAL	Prescription	None	Yes	No
IBRANCE	PALBOCICLIB	125MG	CAPSULE;ORAL	Prescription	None	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 207103

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/03/2015	ORIG-1	Approval	Type 1 - New Molecular Entity	PRIORITY	Label (PDF) Letter (PDF) Review Summary Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207103s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/207103Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/207103Orig1s000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/207103Orig1s000SumR.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
09/06/2023	SUPPL-18	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207103s017s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/207103Orig1s017,s018ltr.pdf
09/06/2023	SUPPL-17	Efficacy-Labeling Change With Clinical Data	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207103s017s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/207103Orig1s017,s018ltr.pdf
12/13/2022	SUPPL-15	Efficacy-New Patient Population	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207103s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/207103Orig1s015;212436Orig1s003ltr.pdf
09/09/2019	SUPPL-12	Labeling-Package Insert, Labeling-Patient Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207103Orig1s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/207103Orig1s012ltr.pdf
09/09/2019	SUPPL-11	Efficacy-Labeling Change With Clinical Data	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207103s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/207103Orig1s011ltr.pdf
02/19/2019	SUPPL-10	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207103s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/207103Orig1s010ltr.pdf
04/04/2019	SUPPL-8	Efficacy-New Patient Population	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207103s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/207103Orig1s008ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/207103Orig1s008.pdf
02/06/2018	SUPPL-7	Efficacy-Labeling Change With Clinical Data	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207103s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/207103Orig1s007ltr.pdf
03/31/2017	SUPPL-4	Efficacy-New Indication	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207103s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/207103Orig1s004ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/207103Orig1s004.pdf
02/19/2016	SUPPL-2	Efficacy-New Indication	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207103s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/207103Orig1s002ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/207103Orig1s002.pdf
12/17/2015	SUPPL-1	Manufacturing (CMC)		Label is not available on this site.

Labels for NDA 207103

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
09/06/2023	SUPPL-18	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207103s017s018lbl.pdf
09/06/2023	SUPPL-17	Efficacy-Labeling Change With Clinical Data	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207103s017s018lbl.pdf
12/13/2022	SUPPL-15	Efficacy-New Patient Population	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207103s015lbl.pdf
09/09/2019	SUPPL-12	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207103Orig1s012lbl.pdf
09/09/2019	SUPPL-12	Labeling-Patient Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207103Orig1s012lbl.pdf
09/09/2019	SUPPL-11	Efficacy-Labeling Change With Clinical Data	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207103s011lbl.pdf
04/04/2019	SUPPL-8	Efficacy-New Patient Population	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207103s008lbl.pdf
02/19/2019	SUPPL-10	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207103s010lbl.pdf
02/06/2018	SUPPL-7	Efficacy-Labeling Change With Clinical Data	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207103s007lbl.pdf
03/31/2017	SUPPL-4	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207103s004lbl.pdf
02/19/2016	SUPPL-2	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207103s002lbl.pdf
02/03/2015	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207103s000lbl.pdf

Top